- Home
- RYTM vs BTG Comparison
RYTM vs BTG Comparison
Compare RYTM & BTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- BTG
- Stock Information
- Founded
- RYTM 2008
- BTG 2006
- Country
- RYTM United States
- BTG Canada
- Employees
- RYTM N/A
- BTG N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- BTG Precious Metals
- Sector
- RYTM Health Care
- BTG Basic Materials
- Exchange
- RYTM Nasdaq
- BTG Nasdaq
- Market Cap
- RYTM 6.4B
- BTG 5.5B
- IPO Year
- RYTM 2017
- BTG N/A
- Fundamental
- Price
- RYTM $96.03
- BTG $4.40
- Analyst Decision
- RYTM Strong Buy
- BTG Buy
- Analyst Count
- RYTM 13
- BTG 3
- Target Price
- RYTM $101.92
- BTG $4.25
- AVG Volume (30 Days)
- RYTM 553.4K
- BTG 35.7M
- Earning Date
- RYTM 11-04-2025
- BTG 11-05-2025
- Dividend Yield
- RYTM N/A
- BTG 2.27%
- EPS Growth
- RYTM N/A
- BTG N/A
- EPS
- RYTM N/A
- BTG N/A
- Revenue
- RYTM $156,287,000.00
- BTG $2,172,330,000.00
- Revenue This Year
- RYTM $44.69
- BTG $66.93
- Revenue Next Year
- RYTM $63.53
- BTG $6.87
- P/E Ratio
- RYTM N/A
- BTG N/A
- Revenue Growth
- RYTM 53.55
- BTG 11.75
- 52 Week Low
- RYTM $45.91
- BTG $2.20
- 52 Week High
- RYTM $106.52
- BTG $4.60
- Technical
- Relative Strength Index (RSI)
- RYTM 46.64
- BTG 64.89
- Support Level
- RYTM $97.47
- BTG $4.01
- Resistance Level
- RYTM $102.46
- BTG $4.34
- Average True Range (ATR)
- RYTM 3.22
- BTG 0.15
- MACD
- RYTM -1.44
- BTG 0.02
- Stochastic Oscillator
- RYTM 13.52
- BTG 67.48
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About BTG B2Gold Corp Common shares (Canada)
B2Gold Corp is an international, low-cost, senior gold mining company. It has three operating open-pit gold mines in Mali, Namibia, and the Philippines and numerous exploration projects across four continents. Other assets include the Gramalote and Kiaka gold projects. The company focuses on acquiring and developing interests in mineral properties with a primary focus on gold deposits as gold production forms all its revenue. There is no dependence on a particular purchaser because the gold is sold into various markets. The company's reportable operating segments include its mining operations and development projects, namely Fekola; Masbate; Otjikoto; the Goose Project, and other mineral properties; and corporate and other.